Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia
Condition(s):LeukemiaLast Updated:June 10, 2021Completed
Hide Studies Not Open or Pending
Condition(s):LeukemiaLast Updated:June 10, 2021Completed
Condition(s):Sarcoma, Soft TissueLast Updated:October 12, 2016Withdrawn
Condition(s):AngiosarcomaLast Updated:April 11, 2016Unknown status
Condition(s):Hepatocellular CarcinomaLast Updated:February 8, 2024Recruiting
Condition(s):MGMT-Unmethylated GlioblastomaLast Updated:January 23, 2023Not yet recruiting
Condition(s):Age-Related Macular Degeneration; Choroidal NeovascularizationLast Updated:March 19, 2012Completed
Condition(s):Biliary Obstructive Disease Such as Choledocholithiasis; Benign Biliary Stricture; Peri-ampullary Cancer; Bile Duct Cancer Resectable; Klatskin TumorLast Updated:January 16, 2019Unknown status
Condition(s):Hepatocellular CarcinomaLast Updated:July 25, 2017Unknown status
Condition(s):Hepatocellular CarcinomaLast Updated:January 9, 2020Unknown status
Condition(s):LymphomaLast Updated:July 10, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.